Equity Analysis

Quarterly Results

    Ajanta Pharma Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    532331
    INE031B01049
    282.5572901
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    AJANTPHARM
    36.75
    32568.33
    EPS(TTM)
    Face Value()
    Div & Yield %:
    70.94
    2
    1.98
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2024Sep 2024Jun 2024
Gross Sales1101.921128.911077.27
Other Operating Income0.000.000.00
Other Income 33.2340.3428.37
Total Income1135.151169.251105.64
Total Expenditure 765.59826.00761.44
PBIDT369.56343.25344.20
Interest 2.480.730.72
PBDT367.08342.52343.48
Depreciation34.9333.3232.92
Tax76.3871.1371.42
Fringe Benefit Tax0.000.000.00
Deferred Tax3.323.093.11
Reported Profit After Tax252.45234.98236.03
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item252.45234.98236.03
EPS (Unit Curr.)20.1618.7518.77
EPS (Adj) (Unit Curr.)20.1618.7518.77
Calculated EPS (Unit Curr.)20.1418.7518.83
Calculated EPS (Adj) (Unit Curr.)20.1418.7518.83
Calculated EPS (Ann.) (Unit Curr.)80.5674.9875.32
Calculated EPS (Adj) (Ann.) (Unit Curr.)80.5674.9875.32
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.001400.000.00
Equity25.0725.0725.07
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)33.5430.4131.95
PBDTM(%)33.3130.3431.88
PATM(%)22.9120.8121.91
Dividend Per Share(Rs)0.0028.000.00
Diluted EPS20.1518.7418.75